Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Nodule | 8 | 2022 | 738 | 2.300 |
Why?
|
| Thyroid Neoplasms | 12 | 2022 | 2225 | 1.880 |
Why?
|
| Watchful Waiting | 1 | 2022 | 451 | 0.680 |
Why?
|
| Thyroidectomy | 2 | 2022 | 887 | 0.660 |
Why?
|
| Thyroid Gland | 2 | 2020 | 1158 | 0.580 |
Why?
|
| Carcinoma, Neuroendocrine | 4 | 2022 | 311 | 0.500 |
Why?
|
| Ultrasonography | 5 | 2022 | 5922 | 0.460 |
Why?
|
| Patient Preference | 1 | 2020 | 867 | 0.460 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2022 | 1059 | 0.350 |
Why?
|
| Thyrotoxicosis | 1 | 2022 | 80 | 0.210 |
Why?
|
| Graves Ophthalmopathy | 1 | 2022 | 95 | 0.190 |
Why?
|
| Graves Disease | 1 | 2022 | 250 | 0.190 |
Why?
|
| Oxyphil Cells | 1 | 2019 | 45 | 0.180 |
Why?
|
| Hashimoto Disease | 1 | 2019 | 94 | 0.170 |
Why?
|
| Pheochromocytoma | 1 | 2021 | 338 | 0.170 |
Why?
|
| Thyrotropin | 2 | 2022 | 817 | 0.170 |
Why?
|
| Calcitonin | 1 | 2019 | 351 | 0.160 |
Why?
|
| Retrospective Studies | 12 | 2022 | 72473 | 0.140 |
Why?
|
| Ki-67 Antigen | 3 | 2022 | 628 | 0.140 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 735 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2020 | 1844 | 0.130 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 2968 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 1124 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2017 | 649 | 0.110 |
Why?
|
| Mutation | 4 | 2021 | 29290 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2555 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2096 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 2939 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 1941 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3424 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2345 | 0.100 |
Why?
|
| Health Surveys | 1 | 2020 | 4036 | 0.090 |
Why?
|
| Middle Aged | 12 | 2021 | 214666 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2790 | 0.090 |
Why?
|
| Humans | 19 | 2022 | 715818 | 0.080 |
Why?
|
| Necrosis | 2 | 2022 | 1645 | 0.080 |
Why?
|
| Genome, Human | 1 | 2020 | 4471 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3741 | 0.070 |
Why?
|
| Male | 13 | 2022 | 350352 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2022 | 23476 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10615 | 0.070 |
Why?
|
| Female | 12 | 2021 | 377229 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2022 | 12535 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2021 | 8047 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8571 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9504 | 0.060 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2022 | 35 | 0.060 |
Why?
|
| Receptors, Thyrotropin | 1 | 2022 | 46 | 0.060 |
Why?
|
| New South Wales | 1 | 2021 | 68 | 0.050 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2021 | 173 | 0.050 |
Why?
|
| Adult | 9 | 2021 | 212279 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 8896 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17409 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 51317 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 649 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 279 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 421 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2021 | 40032 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2019 | 999 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2019 | 374 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 70879 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 996 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 348 | 0.040 |
Why?
|
| Aged | 7 | 2021 | 162468 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15102 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58326 | 0.030 |
Why?
|
| Europe | 1 | 2021 | 3343 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14902 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19537 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 14438 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1801 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56228 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2008 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 790 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1727 | 0.030 |
Why?
|
| Consensus | 1 | 2021 | 2744 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 742 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 3525 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1755 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2720 | 0.030 |
Why?
|
| Biopsy | 1 | 2021 | 6737 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2021 | 3350 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12919 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5947 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15198 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9730 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 85157 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 20733 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29007 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7446 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 41198 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23729 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39305 | 0.010 |
Why?
|
| Child | 1 | 2021 | 74468 | 0.010 |
Why?
|
| United States | 1 | 2021 | 67910 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 62040 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_